Related references
Note: Only part of the references are listed.Botulinum Toxin for the Treatment of Movement Disorders
Mary Ann Thenganatt et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2012)
Flu-Like and Systemic Symptoms Following Treatment with Botulinum Toxins (P01.230)
J. Baizabal Carvallo et al.
NEUROLOGY (2012)
Human T-cell responses to botulinum neurotoxin. Responses in vitro of lymphocytes from patients with cervical dystonia and/or other movement disorders treated with BoNT/A or BoNT/B
Minako Oshima et al.
JOURNAL OF NEUROIMMUNOLOGY (2011)
Flu-like symptoms following botulinum toxin therapy
Jose F. Baizabal-Carvallo et al.
TOXICON (2011)
Studies on the dissociation of botulinum neurotoxin type A complexes
Karl-Heinz Eisele et al.
TOXICON (2011)
Wide-spectrum profile of inflammatory mediators in the plasma and scales of patients with psoriatic disease
Irina Deeva et al.
CYTOKINE (2010)
Immunological characterization of the subunits of type A botulinum neurotoxin and different components of its associated proteins
Roshan Kukreja et al.
TOXICON (2009)
Disease-oriented approach to botulinum toxin use
Joseph Jankovic
TOXICON (2009)
Managing adverse effects of disease-modifying agents used for treatment of multiple sclerosis
Harold Moses et al.
CURRENT MEDICAL RESEARCH AND OPINION (2008)
TRAIL, CXCL10 and CCL2 levels during long-term Interferon-β treatment of patients with multiple sclerosis correlate with flu-like adverse effects but do not predict therapeutic response
Mathias Buttmann et al.
JOURNAL OF NEUROIMMUNOLOGY (2007)
Key elements of bioanalytical method validation for macromolecules
Marian Kelley et al.
AAPS JOURNAL (2007)
Optimization, comparison, and application of colorimetric vs. chemiluminescence based indirect sandwich ELISA for measurement of human IL-23
S Samineni et al.
JOURNAL OF IMMUNOASSAY & IMMUNOCHEMISTRY (2006)
Production of anti-neurotoxin antibody is enhanced by two subcomponents, HA1 and HA3b, of Clostridium botulinum type B16S toxin-haemagglutinin
JC Lee et al.
MICROBIOLOGY-SGM (2005)
Botulinum toxin type A injections:: Adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases
TR Coté et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2005)
Safety of botulinum toxin type A: a systematic review and meta-analysis
M Naumann et al.
CURRENT MEDICAL RESEARCH AND OPINION (2004)
Botulinum toxin in clinical practice
J Jankovic
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2004)
Differential and sequential expression of multiple chemokines during elicitation of allergic contact hypersensitivity
M Goebeler et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Share Paper
